HLAA’s Patient-Focused Drug Development Meeting (Tuesday, May 25, 2021)

HLAA received permission from the U.S. Food & Drug Administration (FDA) to hold an Externally-Led Patient-Focused Drug Development Meeting for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m. (U.S. ET). This meeting represents the voice of the person with hearing loss. Two panels spoke about their experiences living with hearing loss. Meeting attendees had the opportunity to call in and submit online written comments about the issues discussed during the meeting. Most meeting comments collected before, during and in the 30 days following the meeting will be included in a “Voice of the Patient” report published in the fall.

See the full PFDD Meeting transcript (pdf).

Sensorineural Hearing Loss: Externally-Led Patient-Focused Drug Development Meeting (PowerPoint Presentation)
Frank Lin, M.D., Ph.D.
Professor, Departments of Otolaryngology, Medicine, Mental Health & Epidemiology
Director, Cochlear Center for Hearing & Public Health

MEETING AGENDA MEETING FAQs

Partners

Thank you to these organizations and companies who support hearing health care research and solutions.


Questions? Email webinars@hearingloss.org.